{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T11:14:24Z","timestamp":1782731664694,"version":"3.54.5"},"reference-count":95,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Myeloid malignancies including myelodysplastic syndromes, myeloproliferative neoplasms and acute myeloid leukemia are heterogeneous disorders originating from mutated hematopoietic stem and progenitor cells (HSPCs). Genetically, they are very heterogeneous and characterized by uncontrolled proliferation and\/or blockage of differentiation of abnormal HSPCs. Recent studies suggest the involvement of inflammasome activation in disease initiation and clonal progression. Inflammasomes are cytosolic innate immune sensors that, upon activation, induce caspase-1 mediated processing of interleukin (IL) -1-cytokine members IL-1\u03b2 and IL-18, as well as initiation of gasdermin D-dependent pyroptosis. Inflammasome activation leads to a pro-inflammatory microenvironment in the bone marrow, which drives proliferation and may induce clonal selection of mutated HSPCs. However, there are also contradictory data showing that inflammasome activation actually counteracts leukemogenesis. Overall, the beneficial or detrimental effect of inflammasome activation seems to be highly dependent on mutational, environmental, and immunological contexts and an improved understanding is fundamental to advance specific therapeutic targeting strategies. This review summarizes current knowledge about this dichotomous effect of inflammasome activation in myeloid malignancies and provides further perspectives on therapeutic targeting.<\/jats:p>","DOI":"10.3389\/fcell.2021.825611","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T15:17:01Z","timestamp":1643296621000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Inflammasome Activation in Myeloid Malignancies\u2014Friend or Foe?"],"prefix":"10.3389","volume":"9","author":[{"given":"Nicola","family":"Andina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Bonadies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramanjaneyulu","family":"Allam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1182\/blood-2015-11-679985","article-title":"IL1RAP Antibodies Block IL-1-induced Expansion of Candidate CML Stem Cells and Mediate Cell Killing in Xenograft Models","volume":"128","author":"\u00c5gerstam","year":"2016","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","first-page":"10786","DOI":"10.1073\/pnas.1422749112","article-title":"Antibodies Targeting Human IL1RAP (IL1R3) Show Therapeutic Effects in Xenograft Models of Acute Myeloid Leukemia","volume":"112","author":"\u00c5gerstam","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"B3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/leu.2016.249","article-title":"Cathepsin G Is Broadly Expressed in Acute Myeloid Leukemia and Is an Effective Immunotherapeutic Target","volume":"31","author":"Alatrash","year":"2017","journal-title":"Leukemia"},{"key":"B4","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/sj.bjc.6604935","article-title":"Risks of Myeloid Malignancies in Patients with Autoimmune Conditions","volume":"100","author":"Anderson","year":"2009","journal-title":"Br. J. Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.blre.2017.05.001","article-title":"Interleukin-1\u03b2 as Emerging Therapeutic Target in Hematological Malignancies and Potentially in Their Complications","volume":"31","author":"Arranz","year":"2017","journal-title":"Blood Rev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/nature13383","article-title":"Neuropathy of Haematopoietic Stem Cell Niche Is Essential for Myeloproliferative Neoplasms","volume":"512","author":"Arranz","year":"2014","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12185-017-2262-9","article-title":"Complexity of Bone Marrow Hematopoietic Stem Cell Niche","volume":"106","author":"Asada","year":"2017","journal-title":"Int. J. Hematol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1182\/blood-2012-09-458935","article-title":"Selective Killing of Candidate AML Stem Cells by Antibody Targeting of IL1RAP","volume":"121","author":"Askmyr","year":"2013","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","first-page":"6724","DOI":"10.1038\/sj.onc.1210757","article-title":"Hematopoietic Cytokine Receptor Signaling","volume":"26","author":"Baker","year":"2007","journal-title":"Oncogene"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1182\/blood-2018-03-784116","article-title":"Chronic Immune Response Dysregulation in MDS Pathogenesis","volume":"132","author":"Barreyro","year":"2018","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1182\/blood-2016-07-730556","article-title":"The NLRP3 Inflammasome Functions as a Driver of the Myelodysplastic Syndrome Phenotype","volume":"128","author":"Basiorka","year":"2016","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/s0140-6736(05)71142-9","article-title":"Acquired Mutation of the Tyrosine Kinase JAK2 in Human Myeloproliferative Disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"The Lancet"},{"key":"B13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/978-3-662-60309-3_13","volume-title":"Bone Marrow Biopsy Pathology, A Practical Guide","author":"Beham-Schmid","year":"2020"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.3390\/ijms19082155","article-title":"Interleukin-1 Beta-A Friend or Foe in Malignancies?","volume":"19","author":"Bent","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.canep.2019.01.003","article-title":"Trends of Incidence and Survival of Patients with Chronic Myelomonocytic Leukemia between 1999 and 2014: A Comparison between Swiss and American Population-Based Cancer Registries","volume":"59","author":"Benzarti","year":"2019","journal-title":"Cancer Epidemiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.canep.2016.12.005","article-title":"Trends of Classification, Incidence, Mortality, and Survival of MDS Patients in Switzerland between 2001 and 2012","volume":"46","author":"Bonadies","year":"2017","journal-title":"Cancer Epidemiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"5508","DOI":"10.4049\/jimmunol.1202121","article-title":"Cutting Edge: FAS (CD95) Mediates Noncanonical IL-1\u03b2 and IL-18 Maturation via Caspase-8 in an RIP3-independent Manner","volume":"189","author":"Bossaller","year":"2012","journal-title":"J. Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1038\/sj.leu.2401959","article-title":"Expression and Activity of Caspases 1 and 3 in Myelodysplastic Syndromes","volume":"14","author":"Boudard","year":"2000","journal-title":"Leukemia"},{"key":"B19","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/sj.leu.2400654","article-title":"Fas\/Apo-1(CD95) Expression and Apoptosis in Patients with Myelodysplastic Syndromes","volume":"11","author":"Bouscary","year":"1997","journal-title":"Leukemia"},{"key":"B20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1042\/bj20121751","article-title":"The Metalloproteases Meprin \u03b1 and Meprin \u03b2: Unique Enzymes in Inflammation, Neurodegeneration, Cancer and Fibrosis","volume":"450","author":"Broder","year":"2013","journal-title":"Biochem. J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: Mechanism of Assembly, Regulation and Signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"772408","DOI":"10.3389\/fimmu.2021.772408","article-title":"Inflammatory Cytokines Shape an Altered Immune Response during Myeloid Malignancies","volume":"12","author":"Camacho","year":"2021","journal-title":"Front. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1016\/j.celrep.2017.03.018","article-title":"Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia","volume":"18","author":"Carey","year":"2017","journal-title":"Cel Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.1172\/jci67580","article-title":"Induction of Myelodysplasia by Myeloid-Derived Suppressor Cells","volume":"123","author":"Chen","year":"2013","journal-title":"J. Clin. Invest."},{"key":"B25","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.stem.2012.05.027","article-title":"FLT3-ITD Knockin Impairs Hematopoietic Stem Cell Quiescence\/Homeostasis, Leading to Myeloproliferative Neoplasm","volume":"11","author":"Chu","year":"2012","journal-title":"Cell Stem Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A Small-Molecule Inhibitor of the NLRP3 Inflammasome for the Treatment of Inflammatory Diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/carcin\/bgp127","article-title":"Cancer-related Inflammation, the Seventh Hallmark of Cancer: Links to Genetic Instability","volume":"30","author":"Colotta","year":"2009","journal-title":"Carcinogenesis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nrc2047","article-title":"Myelodysplastic Syndromes: the Complexity of Stem-Cell Diseases","volume":"7","author":"Corey","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and Cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3390\/cancers10040104","article-title":"The Critical Role of Inflammation in the Pathogenesis and Progression of Myeloid Malignancies","volume":"10","author":"Craver","year":"2018","journal-title":"Cancers"},{"key":"B31","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1023\/a:1019573319803","article-title":"Risk Factors for Myelodysplastic Syndromes: a Case-Control Study in Greece","volume":"13","author":"Dalamaga","year":"2002","journal-title":"Cancer Causes Control"},{"key":"B32","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1182\/blood-2016-12-754994","article-title":"Targeting the Interleukin-1 Pathway in Patients with Hematological Disorders","volume":"129","author":"de Mooij","year":"2017","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/nejmra1406184","article-title":"Acute Myeloid Leukemia","volume":"373","author":"D\u00f6hner","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41586-021-03341-5","article-title":"The AIM2 Inflammasome Exacerbates Atherosclerosis in Clonal Haematopoiesis","volume":"592","author":"Fidler","year":"2021","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic Inflammation in the Etiology of Disease across the Life Span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.immuni.2016.01.012","article-title":"Human Monocytes Engage an Alternative Inflammasome Pathway","volume":"44","author":"Gaidt","year":"2016","journal-title":"Immunity"},{"key":"B37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.coi.2016.10.007","article-title":"Alternative Inflammasome Activation Enables IL-1\u03b2 Release from Living Cells","volume":"44","author":"Gaidt","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/leu.2015.69","article-title":"Deregulation of Innate Immune and Inflammatory Signaling in Myelodysplastic Syndromes","volume":"29","author":"Ga\u00f1\u00e1n-G\u00f3mez","year":"2015","journal-title":"Leukemia"},{"key":"B39","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1046\/j.1365-2141.1998.00933.x","article-title":"A Role for Tumour Necrosis Factor-\u03b1, Fas and Fas-Ligand in Marrow Failure Associated with Myelodysplastic Syndrome","volume":"103","author":"Gersuk","year":"1998","journal-title":"Br. J. Haematol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/sj.leu.2401233","article-title":"Fas Ligand Expression in the Bone Marrow in Myelodysplastic Syndromes Correlates with FAB Subtype and Anemia, and Predicts Survival","volume":"13","author":"Gupta","year":"1999","journal-title":"Leukemia"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1038\/s41467-020-15497-1","article-title":"Oncogenic KrasG12D Causes Myeloproliferation via NLRP3 Inflammasome Activation","volume":"11","author":"Hamarsheh","year":"2020","journal-title":"Nat. Commun."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.3389\/fimmu.2020.01444","article-title":"NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword","volume":"11","author":"Hamarsheh","year":"2020","journal-title":"Front. Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/nature16959","article-title":"NEK7 Is an Essential Mediator of NLRP3 Activation Downstream of Potassium Efflux","volume":"530","author":"He","year":"2016","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/s0140-6736(07)61165-9","article-title":"LeukemiaNet, on Behalf of the EChronic Myeloid Leukaemia","volume":"370","author":"Hehlmann","year":"2007","journal-title":"Lancet"},{"key":"B45","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/eji.201746947","article-title":"Function and Mechanism of the Pyrin Inflammasome","volume":"48","author":"Heilig","year":"2018","journal-title":"Eur. J. Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ccell.2016.06.002","article-title":"RIPK3 Restricts Myeloid Leukemogenesis by Promoting Cell Death and Differentiation of Leukemia Initiating Cells","volume":"30","author":"H\u00f6ckendorf","year":"2016","journal-title":"Cancer Cell"},{"key":"B47","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/ni.1631","article-title":"Silica Crystals and Aluminum Salts Activate the NALP3 Inflammasome through Phagosomal Destabilization","volume":"9","author":"Hornung","year":"2008","journal-title":"Nat. Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A Unique Clonal JAK2 Mutation Leading to Constitutive Signalling Causes Polycythaemia Vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"B49","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.1182\/blood-2011-12-379008","article-title":"Acute Myeloid Leukemia in the Real World: Why Population-Based Registries Are Needed","volume":"119","author":"Juliusson","year":"2012","journal-title":"Blood"},{"key":"B50","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41568-019-0123-y","article-title":"Diverging Inflammasome Signals in Tumorigenesis and Potential Targeting","volume":"19","author":"Karki","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"B51","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature10558","article-title":"Non-canonical Inflammasome Activation Targets Caspase-11","volume":"479","author":"Kayagaki","year":"2011","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ccell.2015.04.006","article-title":"SRSF2 Mutations Contribute to Myelodysplasia by Mutant-specific Effects on Exon Recognition","volume":"27","author":"Kim","year":"2015","journal-title":"Cancer Cell"},{"key":"B53","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nri3062","article-title":"Inflammatory Modulation of HSCs: Viewing the HSC as a Foundation for the Immune Response","volume":"11","author":"King","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1053\/j.seminhematol.2018.05.002","article-title":"Increased Cardiovascular Comorbidities in Patients with Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia Presenting with Systemic Inflammatory and Autoimmune Manifestations","volume":"55","author":"Kipfer","year":"2018","journal-title":"Semin. Hematol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s13238-013-0001-4","article-title":"Inflammasomes in Cancer: a Double-Edged Sword","volume":"5","author":"Kolb","year":"2014","journal-title":"Protein Cell"},{"key":"B56","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1182\/blood-2016-09-670224","article-title":"Myeloid Malignancies and the Microenvironment","volume":"129","author":"Korn","year":"2017","journal-title":"Blood"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1056\/nejmoa051113","article-title":"A Gain-Of-Function Mutation ofJAK2in Myeloproliferative Disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nri3452","article-title":"Activation and Regulation of the Inflammasomes","volume":"13","author":"Latz","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating Mutation in the Tyrosine Kinase JAK2 in Polycythemia Vera, Essential Thrombocythemia, and Myeloid Metaplasia with Myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40164-016-0032-7","article-title":"Identification of AIM2 as a Downstream Target of JAK2V617F","volume":"5","author":"Liew","year":"2016","journal-title":"Exp. Hematol. Oncol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1056\/nejmoa1010222","article-title":"Cytarabine Dose for Acute Myeloid Leukemia","volume":"364","author":"L\u00f6wenberg","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/imr.12534","article-title":"Molecular Mechanisms and Functions of Pyroptosis, Inflammatory Caspases and Inflammasomes in Infectious Diseases","volume":"277","author":"Man","year":"2017","journal-title":"Immunol. Rev."},{"key":"B63","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 Inflammasome in Inflammatory Diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"B64","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1146\/annurev.immunol.021908.132715","article-title":"The Inflammasomes: Guardians of the Body","volume":"27","author":"Martinon","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.immuni.2012.08.027","article-title":"NLRP1 Inflammasome Activation Induces Pyroptosis of Hematopoietic Progenitor Cells","volume":"37","author":"Masters","year":"2012","journal-title":"Immunity"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1016\/j.celrep.2013.04.031","article-title":"FLT3-ITDs Instruct a Myeloid Differentiation and Transformation Bias in Lymphomyeloid Multipotent Progenitors","volume":"3","author":"Mead","year":"2013","journal-title":"Cel Rep."},{"key":"B67","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3389\/fimmu.2016.00390","article-title":"The Role of Toll-like Receptors in Hematopoietic Malignancies","volume":"7","author":"Monlish","year":"2016","journal-title":"Front. Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature12984","article-title":"The Bone Marrow Niche for Haematopoietic Stem Cells","volume":"505","author":"Morrison","year":"2014","journal-title":"Nature"},{"key":"B69","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/ejh.12256","article-title":"Epidemiology of Myelofibrosis, Essential Thrombocythemia, and Polycythemia Vera in the European Union","volume":"92","author":"Moulard","year":"2014","journal-title":"Eur. J. Haematol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1182\/blood.v88.7.2640.bloodjournal8872640","article-title":"Indication of an Involvement of Interleukin-1 Beta Converting Enzyme- like Protease in Intramedullary Apoptotic Cell Death in the Bone Marrow of Patients with Myelodysplastic Syndromes","volume":"88","author":"Mundle","year":"1996","journal-title":"Blood"},{"key":"B71","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1146\/annurev-immunol-032414-112306","article-title":"Inflammasome-Independent Regulation of IL-1-Family Cytokines","volume":"33","author":"Netea","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.leukres.2011.06.001","article-title":"Incidence and Prevalence of Myelodysplastic Syndromes: Data from the D\u00fcsseldorf MDS-Registry","volume":"35","author":"Neukirchen","year":"2011","journal-title":"Leuk. Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.ccell.2016.08.006","article-title":"Physiologic Expression of Sf3b1 K700E Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation","volume":"30","author":"Obeng","year":"2016","journal-title":"Cancer Cell"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1038\/sj.cdd.4402195","article-title":"Activation of the NALP3 Inflammasome Is Triggered by Low Intracellular Potassium Concentration","volume":"14","author":"P\u00e9trilli","year":"2007","journal-title":"Cell Death Differ"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1182\/blood-2008-03-144790","article-title":"Molecular Biology of Bcr-Abl1-Positive Chronic Myeloid Leukemia","volume":"113","author":"Quint\u00e1s-Cardama","year":"2009","journal-title":"Blood"},{"key":"B76","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1182\/blood-2019-129800","article-title":"IL-1\u03b2 Secreted from Mutant Cells Carrying JAK2-V617Ffavors Early Clonal Expansion and Promotes MPN Disease Initiation and Progression","volume":"134","author":"Rai","year":"2019","journal-title":"Blood"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1038\/s41375-020-0827-8","article-title":"The Nlrp3 Inflammasome as a \u201cRising star\u201d in Studies of normal and Malignant Hematopoiesis","volume":"34","author":"Ratajczak","year":"2020","journal-title":"Leukemia"},{"key":"B78","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.beha.2009.07.007","article-title":"Epidemiology of Chronic Myeloid Leukaemia (CML)","volume":"22","author":"Rohrbacher","year":"2009","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1182\/blood-2018-10-844654","article-title":"The central Role of Inflammatory Signaling in the Pathogenesis of Myelodysplastic Syndromes","volume":"133","author":"Sallman","year":"2019","journal-title":"Blood"},{"key":"B80","doi-asserted-by":"publisher","first-page":"E10888","DOI":"10.1073\/pnas.1809548115","article-title":"Caspase-8 Induces Cleavage of Gasdermin D to Elicit Pyroptosis duringYersiniainfection","volume":"115","author":"Sarhan","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"B81","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The Inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"B82","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1182\/blood.v108.11.4430.4430","article-title":"Elevated Serum Neutrophil Elastase but Not Proteinase 3 Is Present in Patients with Myeloid Leukemia","volume":"108","author":"Sergeeva","year":"2006","journal-title":"Blood"},{"key":"B83","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature13683","article-title":"Inflammatory Caspases Are Innate Immune Receptors for Intracellular LPS","volume":"514","author":"Shi","year":"2014","journal-title":"Nature"},{"key":"B84","doi-asserted-by":"publisher","first-page":"e72138","DOI":"10.1371\/journal.pone.0072138","article-title":"S100A8 and S100A9 Induce Cytokine Expression and Regulate the NLRP3 Inflammasome via ROS-dependent Activation of NF-\u03baB1","volume":"8","author":"Simard","year":"2013","journal-title":"PLoS ONE"},{"key":"B85","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 Inflammasome: Molecular Activation and Regulation to Therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"B86","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2017"},{"key":"B87","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern Recognition Receptors and Inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"B88","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1001\/jamaoncol.2015.89","article-title":"Myeloproliferative Neoplasms","volume":"1","author":"Tefferi","year":"2015","journal-title":"Jama Oncol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jcyt.2020.01.001","article-title":"Interleukin-1\u03b2 Inhibits normal Hematopoietic Expansion and Promotes Acute Myeloid Leukemia Progression via the Bone Marrow Niche","volume":"22","author":"Wang","year":"2020","journal-title":"Cytotherapy"},{"key":"B90","doi-asserted-by":"publisher","first-page":"630479","DOI":"10.3389\/fcell.2021.630479","article-title":"Targeting the NLRP3 Inflammasome via BTK","volume":"9","author":"Weber","year":"2021","journal-title":"Front. Cel Dev. Biol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.4161\/cbt.29922","article-title":"Production of IL-1\u03b2 by Bone Marrow-Derived Macrophages in Response to Chemotherapeutic Drugs","volume":"15","author":"Wong","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"B92","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","article-title":"Pyroptosis: Mechanisms and Diseases","volume":"6","author":"Yu","year":"2021","journal-title":"Sig. Transduct. Target. Ther."},{"key":"B93","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1182\/blood-2015-11-679928","article-title":"Inhibition of Interleukin-1 Signaling Enhances Elimination of Tyrosine Kinase Inhibitor-Treated CML Stem Cells","volume":"128","author":"Zhang","year":"2016","journal-title":"Blood"},{"key":"B94","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.intimp.2011.01.007","article-title":"Icariin and its Derivative, ICT, Exert Anti-inflammatory, Anti-tumor Effects, and Modulate Myeloid Derived Suppressive Cells (MDSCs) Functions","volume":"11","author":"Zhou","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A Role for Mitochondria in NLRP3 Inflammasome Activation","volume":"469","author":"Zhou","year":"2010","journal-title":"Nature"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.825611\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T15:17:07Z","timestamp":1643296627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.825611\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":95,"alternative-id":["10.3389\/fcell.2021.825611"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2021.825611","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]},"article-number":"825611"}}